BioLumen

BiotechnologySeedSan Francisco, USbiolumen.tech

Latest round

Seed

Last raised

Jun 2022

Total raised

Undisclosed

Investors

2

About BioLumen

Founded in 2018, BioLumen Inc specializes in bioluminescence systems for environmental monitoring and medical diagnostics. The company is headquartered in San Francisco, US. Jhon Tabares and Paolo Costa are the founders, with Paolo Costa currently serving as CEO.Biolumen Tech specializes in innovative solutions within the biotechnology sector, focusing on advanced light-based technologies for various applications. Their core product offerings include sophisticated bioluminescence systems designed for research and industrial purposes, which aid in environmental monitoring, medical diagnostics, and agricultural efficiency. These products function by leveraging unique biochemical reactions to produce measurable light outputs, allowing users to assess biological activity and detect specific compounds or pathogens. The company serves a diverse client base comprising research institutions, pharmaceutical companies, and agricultural enterprises across North America, Europe, and parts of Asia.Biolumen Tech generates revenue through direct sales and partnerships with research institutions and commercial entities in biotechnology. The company employs a B2B transaction structure, facilitating the sale of its bioluminescence systems and associated services directly to life sciences clients. Revenue streams are solidified through subscription models for ongoing technical support and software updates related to their products. Flagship offerings, including proprietary bioluminescent assays and diagnostic kits, contribute significantly to the financial performance of the company.BioLumen Inc plans to launch new products designed for enhanced bioluminescent applications, with specific release dates pending. The company is targeting expansion into European and Asian markets by late 2023, seeking to increase its global footprint.

Who invested in BioLumen

2 investors across 2 rounds

See all investors in BioLumen

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jun 24, 2022

    Amount

    Undisclosed

    Investors

    Locked

  2. Seed

    Nov 5, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about BioLumen

Who invested in BioLumen?

BioLumen has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has BioLumen raised?

BioLumen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did BioLumen last raise money?

BioLumen's most recent round on record is a Seed, in Jun 2022.

What does BioLumen do?

Founded in 2018, BioLumen Inc specializes in bioluminescence systems for environmental monitoring and medical diagnostics.

Where is BioLumen headquartered?

BioLumen is headquartered in San Francisco, US.

Which VCs invest in companies like BioLumen?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioLumen's stage. Their profiles are linked below.

Raising like BioLumen? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.